Who
Michael Nohaile
Director
Company insider
Files Form 4 as: Director, Fulgent Genetics.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Aug 2022
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —5,558 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FLGT Fulgent Geneticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —8,426 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FLGT Fulgent Geneticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —8,426 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —5,558 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | FLGT Fulgent Geneticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,311 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —4,491 at $0.00 | filing |
| 16 May 2024filed 20 May 2024 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | FLGT Fulgent Geneticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,380 at $0.00 | filing |
| 18 May 2023filed 22 May 2023 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —2,529 at $0.00 | filing |
| 1 Aug 2022filed 10 Aug 2022 | FLGT Fulgent Geneticsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Aug 2022filed 10 Aug 2022 | FLGT Fulgent GeneticsDiagnostics & Labs | SEC FORM 4 Code A | —4,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.